Hepatotoxicity and accelerated fibrosis following 3,4-methylenedioxymetamphetamine ("ecstasy") usage.
3,4-Methylenedioxymetamphetamine ("ecstasy") has previously been reported to cause an acute hepatitis that may progress to liver failure. We present the first recorded case of ecstasy-induced accelerated hepatic fibrosis.
Khakoo
S I
SI
Department of Medicine, Bristol Royal Infirmary, England.
Coles
C J
CJ
Armstrong
J S
JS
Barry
R E
RE
D000328:Adult; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology* / Q000473:pathology; D005260:Female; D006801:Humans; D008099:Liver / Q000187:drug effects / Q000473:pathology; D008103:Liver Cirrhosis / Q000139:chemically induced* / Q000473:pathology; D018817:N-Methyl-3,4-methylenedioxyamphetamine / Q000009:adverse effects*
D018817:N-Methyl-3,4-methylenedioxyamphetamine